Giuseppe Ronzitti News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Giuseppe ronzitti. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Giuseppe Ronzitti Today - Breaking & Trending Today

Trial demonstrates efficacy of gene therapy in patients suffering from Crigler-Najjar syndrome, a rare liver disease

Trial demonstrates efficacy of gene therapy in patients suffering from Crigler-Najjar syndrome, a rare liver disease
medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.

Noord Holland , France General , Azienda Ospedaliera Papa Giovanni , Piter Bosma , Ulrich Beuers , Giuseppe Ronzitti , Lorenzo Dantiga , Academic Medical Center , European Medicines Agency , New England Journal , Liver Disease Immunology , Gene Therapy , Lorenzod Antiga , Crigler Najjar Syndrome , Najjar Syndrome ,

Genethon Given PRIME Status by EMA for Gene Therapy To Treat Crigler-Najjar Syndrome, a Rare Liver Disease

Genethon, a unique non-profit gene therapy R&D organization founded by the French Muscular Dystrophy Association (AFM-Telethon), today announced that the European Medicines Agency (EMA) has granted PRIME ....

Giuseppe Ronzitti , Dennis Riedl , Stephanie Bardon , Charles Craig , Frederic Revah , French Muscular Dystrophy Association , European Medicines Agency , Priority Medicines , Gene Therapy , Liver Diseases ,

Preliminary results of AAV-mediated gene therapy for Crigler Najjar syndrome


Preliminary results of AAV-mediated gene therapy for Crigler Najjar syndrome
Preliminary results from the European gene therapy trial for Crigler-Najjar syndrome, conducted by Genethon in collaboration with European network CureCN, were presented at the EASL (European Association for the Study of the Liver) annual International Liver Congress on June 26. Based on initial observations, the drug candidate is well tolerated and the first therapeutic effects have been demonstrated, to be confirmed as the trial continues.
Crigler-Najjar syndrome is a rare genetic liver disease characterized by abnormally high levels of bilirubin in the blood (hyperbilirubinemia). This accumulation of bilirubin is caused by a deficiency of the UGT1A1 enzyme, responsible for transforming bilirubin into a substance that can be eliminated by the body, and can result in significant neurological damage and death if not treated quickly. At present, patients must undergo phototherapy for up to 12 hours ....

Giuseppe Ronzitti , Crigler Najjar , Lorenzo Dantiga , Frederic Revah , Emily Henderson , International Liver Congress On , European Association , International Liver Congress , Lorenzod Antiga , Azienda Ospedaliera Papa Giovanni , Liver Gene Therapy , எமிலி ஹென்டர்சன் , ஐரோப்பிய சங்கம் , சர்வதேச கல்லீரல் காங்கிரஸ் ,